[The first experience of the use the Russian Β-interferon-1b biosimilar (infibeta) in the daily practice of the Moscow Center of Multiple Sclerosis.] Popova EV, Boĭko AN, Davydovskaia MV, Demina TL, Kukel' TM, Lashch IN, Popova NF, Khachanova NV, Shchur SG, Gusev EI Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):93-96. PMID: 24300821. Abstract CommentRecommendBookmarkWatch